These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 29788997)

  • 1. 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling.
    Centeno EGZ; Cimarosti H; Bithell A
    Mol Neurodegener; 2018 May; 13(1):27. PubMed ID: 29788997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.
    Zhang X; Hu D; Shang Y; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling neurodegenerative diseases with 3D brain organoids.
    Chang Y; Kim J; Park H; Choi H; Kim J
    Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
    Mungenast AE; Siegert S; Tsai LH
    Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
    Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H
    Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
    Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural patterning of human induced pluripotent stem cells in 3-D cultures for studying biomolecule-directed differential cellular responses.
    Yan Y; Bejoy J; Xia J; Guan J; Zhou Y; Li Y
    Acta Biomater; 2016 Sep; 42():114-126. PubMed ID: 27345135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
    Garcia-Leon JA; Vitorica J; Gutierrez A
    Future Med Chem; 2019 Jun; 11(11):1305-1322. PubMed ID: 31161803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases.
    Trudler D; Ghatak S; Lipton SA
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model.
    Baronchelli S; La Spada A; Ntai A; Barbieri A; Conforti P; Jotti GS; Redaelli S; Bentivegna A; De Blasio P; Biunno I
    Mol Cell Neurosci; 2017 Jul; 82():46-57. PubMed ID: 28476540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
    Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
    Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
    Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
    N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.